The institutional investor acquired 10,973 shares of the company’s stock ... sell-side analysts predict that Takeda Pharmaceutical Company Limited will post 1.64 EPS for the current year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback